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We thank Dr. Finsterer for his interest [1] in our work [2].
The patient presented initially with generalized hypotonia and ex-
aggerated tendon reflexes and progressively developed spasticity and
dystonia. This is not uncommon in cases of pyramidal tract involvement
of central origin and is often seen in premature-born babies with peri-
ventricular leucomalacia, first exhibiting a variable degree of hypotonia
and later on develop hypertonia (i.e. spasticity).
Regarding the twin sister, no autopsy was performed, thus no in-
formation can be obtained as of her phenotypic or genotypic features
and if an mtDNA depletion syndrome was involved.
Regarding respiratory chain complex functions, we considered that
the overall respiratory chain activity of the patient fibroblasts is normal
because when using glucose, oxygen consumption rates were not dif-
ferent from those of controls (figure panels 3C and 4E in [2]). Fur-
thermore, baseline mitochondrial membrane potential (ΔΨm) values
during state 2 and state 3 respiration normalized to maximal depolar-
ization caused by the uncoupler SF6847 (Fig. 2, before and after ad-
dition of ADP, respectively), were also not different. This means that
the changes in individual respiratory complex activities –if any- didn't
confer a sufficient damage for impairing overall respiratory chain
function. This is important, because we could not compare respiratory
chain component activities of the patient fibroblasts (i.e. n= 1) to three
controls using a sufficiently robust statistical test.
Regarding the possibility of greater mtDNA depletion and/or re-
spiratory chain complex dysfunctions in severely affected tissues such
as the brain, we reiterate what we wrote in the manuscript, namely that
this may well be possible. Having said that, we emphasize that we do
not support pursuing brain sampling at autopsy; as this is performed
only rarely for a number of reasons and in view of the fact of the rarity
of the disease itself, a sufficient number of patients for mtDNA and
respiratory chain complex function determinations may take decades to
pool. Instead, we underscore that mtDNA and respiratory chain com-
plex function determinations from fibroblasts does not reflect the se-
verity of the disease in other tissues; however, oxygen consumption
rates using glutamine instead of glucose, imaging of mitochondrial
morphology and measuring mitochondrial substrate-level phosphor-
ylation in cultured skin fibroblasts do provide definite answers re-
garding the impact of succinate-CoA ligase deficiency on mitochondrial
bioenergetics, rendering brain autopsy procedures obsolete.
Regarding more conclusively explaining the reduction and mis-
localization of SUCLG2 protein in view of the mutation in SUCLG1
gene, this finding is indeed worth pursuing on its own. Mindful that to
the best of our knowledge, known molecular biology/signal
transduction pathways cannot offer a suitable insight and because the
cultured fibroblasts of the deceased patient will exhibit senescence after
a defined number of divisions, experiments to address this observation
are planned so as to minimize the chance of running out of this crucial
biological material.
Concerning the dissimilar phenotype between the father and the
daughter despite the same genotype, at the cDNA level the c.626C > A
mutation was found to be homozygous and therefore we described the
patient as functionally homozygous for this mutation [2]. The maternal
allele was not expressed and the underlying cause has not been iden-
tified. Multiplex ligation-dependent probe amplification excluded the
possibility of a larger deletion. Further analysis of the cause for not
expressing the maternal allele would not only require analyses of the
SUCLG1 introns but also a search for a pathogenic mutation in the
promotor regions of this gene or in the 3′ untranslated region (UTR) of
the gene that can cause allelic expression imbalance [3].
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